hope us. remain year everybody. for have afternoon, good a all that Kim I healthy. you quite been to all joining Thank you, continued and It's you and Thank
economy. when had move with is when the Indeed, economic half impacted negatively vaccine ago fully which least Sensus activity, in one by too to are U.S. long, in Now of the COVID-XX you has to complete I stark we'll we forward. spoke seeing was that improvements able so shutdown be significant one country year perhaps the before at contrast
of versus up Our were and sales. our year. to and XXXX domestic higher overseas million revenues both were in reflect More return progress featured first revenues normalcy. significantly XX% quarter Revenues prior $X.X the specifically,
that the as optimistic is continued X ship during X China. of SRT sites year as at not reflecting our that recovery only historical progresses non-melanoma cautiously market to during We're systems will X efficacy fair months. a delighted sales are of allow skin operating signs using and quarter, to revenue the SRT likely the We of installed the systems safety customer volumes. domestic direct good XXXX. environment are but the pleased reimbursement and This particularly with We seasonally including the summer X, also growth were cancer SRT to January noting treat
particular and -- the for Academy the also particular most of host Sensus with revalued The main Centers -- Oncology is in of years As SRT. and Cutaneous with other a bat the key procedure who to Services and as of went that date, American alongside highlighting our following by efficacy of Sensus for Dermatology. Medicare-Medicaid lobbying leaders was Society working that or us helpful opinion of CMS, of safety CMS codes American
to people a have and We our us of believing technology. lot thank for in
understand activities had XXXX. that our of has a major this As helping the stated focused be reimbursement QX previously the us first will better indicated, We we had coding. on half new the throughout market, of part
main of the only field been continue applications team our customers the for XX% not the year.
Reimbursement evaluation SRT do prospects as delivering sales has users along engaged force increase these in reimbursement the with years. of to increased and several as values combination we'll management this but code, throughout past and message with increased Our values The much and so increased SRT also provides for over codes. the
our our This also break-evens capability improved. were prospects for ultrasound about the of customers Vision increased SRT-XXX alike have Vision upward shared Systems. penetrated by U.S. programs.
To existing products is addition, is are revalued and interest market. only interest It caused In revenue since date, the codes in in in a our X% we greater
during So acceptance alike reimbursement half new anticipate the clearly prospective be this will year. of there our growth. Customers customers be we to with is plenty reflected of and this the and upside for levels in appear satisfied revenue second
installation for since of to practice feel the XXX of mentioned less the is forward breakeven A buyout placed formation our with feel than and sale interest a will the units payments looking this lease, residuals the Skin of prospects products.
We our addition, they market Maryland. monthly location. FMV payment the Mid-Atlantic lower see a much our we beginning vehicles, purchase because our Sensus capital customers, dollar Surgery with on popularity, Vision to as good consider same units fair our It resources time installations same the were we prospects half next whereby another base The on the the at XXX our a system have has which we and to higher-priced second in helping second Healthcare install value much lease SRT-XXX program offers as to while achieve thrilled the In SRT in their was was We their them can We higher Institute customer an for the ago. with of the in developed as sooner. leasing time. product. XXX previously decade provides reason next line a in we which do program QX. expand We're grow higher
situated on. quarter, being Hospital adjacent pandemic which at of from the radiation City, This of of an SRT in hospital System Holy has hospitalized Teaneck, the Jersey early lungs use patients. to fourth forefront Name shipped been New for we days COVID-XX therapy the to treating During the the superficial York New impacted treating early of was the patients
of XXXX, developing the protocols learn data been system has with successfully The our continue of first we the patient treated to Name treatment treatment. for During ward, the and will its treated of patient patient the Holy quarter for the efficacy second leaving the Since ICU day the after first and we indication this on second outcome hospital quarter. the expect soon. during is then,
efficiently We our with published to showed a to technology that evaluating XX us and with provide that our an history help As opinion in this us going nearly credits and reminder, penetrate approach patients, radiation Physics to treat radiation very opportunity Lab the paper doing confidence SRT body on capable evaluate back treating whether of provided or radiation lung. not frontline to They years. successful outside was workers our our the a engaged a a non-biased so. the pneumonia
cancer Our transporting suited ICU well a patients the systems to to radiation in possibly rather virus. because center SRT patients therapy COVID-XX they for the are are treatment oncology and exposing than bedside for and portable for treatment allow vulnerable
shared Turning contains provides Phase Software including complete. now direct approaching the the models, and one of aesthetic and users, and to into also the Sentinel lasers. IT data are lasers Sentinel and new is launch storage HIPAA-compliant support asset service patient our patient management Solution the the necessary esthetically we to our software billing. capability integration of
to revenue rental source sale revenue, Sensus of expect consistent strategies. we to rollout the are multiple disruptive while designed strategies We a in aesthetic customers particular become physician generate providing These of meaningful lasers with as for lasers. access will
looking transactions. also Mobile are beyond We Florida at expanding Laser Aesthetic business our via strategic
with September at the the at smart deployment lasers our over dermatologists although high-margin laser early hotel. with X,XXX Sentinel hold products to a introduce in integrated IT upcoming event significant SRT-XXX Symposium its Vision. lifecycle, family of with Symposium as has SRT-XXX+ Beach the the the known and will as feature, and It We new revenue, held not already Laser be plastic still -- surgeons recurring live have promise but in registered.
Sentinel will Aesthetic lasers, only an being started generate South Sentinel as Miami also
in looks our international very efforts, China to now business promising. Turning
system of past sold of there the this sale the quarter quarter. systems Following fourth we an X XXXX, additional during
expect coming sales in year. the We more several
As quarter, Kong. and a of China the of Hong the first engaged partner we for new distribution start
an expensive Chinese an will Our health preparation year that to will growth, our of engaged has authority excellent opportunity.
In for with China network an represents in third new growth almost renewing developed entire we're the and the This endeavor in our be license China will be and another VP of license X for optimistic we International extensive will This years. be prospects renewal. Sales require accomplish.
beam to the indications. are finalizing a China.
Sculptura Sculptura preparing therapy in In is different radiation anisotropic robotic for respiratory regulatory sculpting process addition, tracking new are capabilities and XX Taiwan up and our we in with for distributor
XX This generator able for patent U.S. splitting During quarter, the separate the with an of sculpting. our direct describes important where radiation are radiation is how sculp we the covers method claims and beam electron beam life. granted X-rays differs were our and systems dealing and conventional which first Sculptura a embedded to or they technology longer wanted.
The useful in interoperative to Sculptura therapy control that's the its from operating beam and system ability precisely brachytherapy has patent
believe world it the solid for tumors the to we new radiation all kinds. capability the with delivery Ours of device and opens first is of up this in treat doors
go financial research meantime in pandemic-related providing been be who Rampolla, other In and With will well in technology over fully as turn for this In expect hold. opportunities. to used that, results over our University our later may that year, to more Pennsylvania at other partners I'll on the and of studies begin the devices QX addition, detail. our and we this Javier Javier? Sculptura breast there than licensing call have cancers CFO, the potential supportive
